Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Little, K. Y. Articles by Cassin, B. J. Search for Related Content PubMed Citation Articles by Little, K. Y. Articles by Cassin, B. J. Neurotransmitters Cocaine

Loss of Striatal Vesicular Monoamine Transporter Protein (VMAT2) in Human Cocaine Users

OBJECTIVE: The hypothesis that human cocaine users lose vesicular monoamine transporter (VMAT2) protein was tested in striatal samples from cocaine users and age-, sex-, and postmortem interval-matched comparison subjects. METHOD: Striatal samples were retrieved at autopsy; immunoblot assays were then performed by using a highly specific VMAT2 antibody. Striatal radioligand binding to VMAT2 was assessed with dihydrotetrabenazine ([³H]DTBZ) and dopamine levels employing high-performance liquid chromatography. RESULTS: Cocaine users displayed a marked reduction in VMAT2 immunoreactivity as well as reduced [³H]DTBZ binding and dopamine levels. It did not appear that the reduction in VMAT2 immunoreactivity was related to ethanol use, but dopamine levels were lower in subjects with only ethanol diagnoses. Subjects suffering from cocaine-induced mood disorders displayed a greater loss of VMAT2 immunoreactivity that approached significance. CONCLUSIONS: Human cocaine users lose VMAT2 protein, which might reflect damage to striatal dopamine fibers. These neuronal changes could play a role in causing disordered mood and motivational processes in more severely dependent patients.

This article has been cited by other articles:

				D. Martinez, R. Narendran, R. W. Foltin, M. Slifstein, D.-R. Hwang, A. Broft, Y. Huang, T. B. Cooper, M. W. Fischman, H. D. Kleber, et al. Amphetamine-Induced Dopamine Release: Markedly Blunted in Cocaine Dependence and Predictive of the Choice to Self-Administer Cocaine Am J Psychiatry, April 1, 2007; 164(4): 622 - 629. [Abstract] [Full Text] [PDF]

				Z. Lin, D. Walther, X.-Y. Yu, S. Li, T. Drgon, and G. R. Uhl SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism Hum. Mol. Genet., May 15, 2005; 14(10): 1393 - 1404. [Abstract] [Full Text] [PDF]

				D. Milne Cocaine Appears to Damage Brain's Dopamine Neurons Psychiatr News, February 7, 2003; 38(3): 22 - 22. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us